Latin American market expands for Raymedica's disc:
This article was originally published in Clinica
Executive Summary
Argentina, Brazil and Mexico have approved for sale Raymedica's PDN prosthetic nucleus disc device for treating low-back pain. The device has already been approved for sale in Chile and Venezuela. Latin America, where reimbursement rates for devices such as the PDN implant are equivalent to those of European countries, represents a significant market opportunity, says the Minneapolis, Minnesota firm. Argentina, Brazil and Mexico have a combined population of more than 300 million and the medical device import markets in these countries are growing at an average of 12% annually, it adds.